Fig. 1.
Fig. 1. VE-cadherin distribution on cultured human umbilical vein endothelial cells (HUVECs) in the presence of PMN transmigration. / (A-B) Specimens were fixed with 4% paraformaldehyde in the presence of 0.5% Triton-X 100 and subsequently immunostained with anti–VE-cadherin antibody and fluorescence-conjugated secondary antibody. (C-F) Specimens were prelabeled with the primary antibody against VE-cadherin, fixed, and finally labeled with the secondary antibody. Confocal fluorescence micrographs B, D, and F were taken from the same specimens from which phase-contrast micrographs A, C, and E were taken. Triangle symbols indicate the locations of transmigrating PMNs. PMNs on top of the endothelial cells are marked by arrows, and PMNs already transmigrated are marked by asterisks.

VE-cadherin distribution on cultured human umbilical vein endothelial cells (HUVECs) in the presence of PMN transmigration.

(A-B) Specimens were fixed with 4% paraformaldehyde in the presence of 0.5% Triton-X 100 and subsequently immunostained with anti–VE-cadherin antibody and fluorescence-conjugated secondary antibody. (C-F) Specimens were prelabeled with the primary antibody against VE-cadherin, fixed, and finally labeled with the secondary antibody. Confocal fluorescence micrographs B, D, and F were taken from the same specimens from which phase-contrast micrographs A, C, and E were taken. Triangle symbols indicate the locations of transmigrating PMNs. PMNs on top of the endothelial cells are marked by arrows, and PMNs already transmigrated are marked by asterisks.

Close Modal

or Create an Account

Close Modal
Close Modal